Moderna, Inc.
เพิ่มขึ้น

MRNA LONG CALL

MRNA has been consolidating and testing its resistance at 66.96, also it's hoping to begin a phase 3 trial in the coming weeks.
HUGE GAP UP can consider long call.
Technical Indicators

คำจำกัดสิทธิ์ความรับผิดชอบ